What clinical trials are available for metastatic Breast Cancer

Clinical Trials for Metastatic Breast Cancer

I appreciate your question about clinical trials. However, I need to be transparent: I don't have access to a current, searchable database of active clinical trials in my provided medical guidelines. What I can do is explain how to find them and what types of trials are being conducted based on current treatment approaches.

How to Find Active Clinical Trials

The most reliable resource is:

• ClinicalTrials.gov - This is the official U.S. National Institutes of Health (NIH) database where you can search by:
  • Cancer type (metastatic breast cancer)
  • Your specific biomarkers (HER2 status, hormone receptor status, etc.)
  • Location/institution
  • Treatment phase (Phase 1, 2, 3)
  • Your eligibility criteria

Types of Trials Currently Being Conducted

Based on NCCN Guidelines and current breast cancer research, trials are actively enrolling patients for:

HER2-Positive Metastatic Breast Cancer:

• Tucatinib combinations - The HER2CLIMB trial showed tucatinib + trastuzumab + capecitabine significantly improved outcomes, including for patients with brain metastases
• Trastuzumab deruxtecan (T-DXd) - An antibody-drug conjugate showing strong efficacy
• Neratinib combinations - The NALA trial compared neratinib + capecitabine vs. lapatinib + capecitabine

Hormone Receptor-Positive (HR+) Metastatic Breast Cancer:

• Capivasertib + fulvestrant - According to ASCO Guidelines, this combination targets aromatase inhibitor-resistant disease
• CDK4/6 inhibitor combinations - Ongoing trials with endocrine therapy
• Novel targeted therapies for specific mutations (PIK3CA, ESR1, AKT1)

Triple-Negative Breast Cancer:

• Immunotherapy combinations - Pembrolizumab with chemotherapy
• PARP inhibitors - For BRCA-mutated patients
• Targeted therapies based on tumor mutations

Brain Metastases (Special Consideration):

According to NCCN Brain Metastases Guidelines, trials are testing:

• Tucatinib + trastuzumab + capecitabine (FDA-approved, but trials ongoing)
• Neratinib + capecitabine
• Trastuzumab deruxtecan for HER2-positive disease with CNS involvement

Questions to Ask Your Oncologist

1. "Are there any clinical trials I'm eligible for based on my specific biomarkers?"
2. "What phase trial would be appropriate for my situation?" (Phase 1 = safety/dosage; Phase 2 = efficacy; Phase 3 = comparison to standard care)
3. "What are the potential benefits and risks of trial participation vs. standard treatment?"
4. "Will the trial be at our institution or require travel?"
5. "How will my progress be monitored in the trial?"

Key Resources

• ClinicalTrials.gov - Search directly for metastatic breast cancer trials
• Cancer.gov - NCI's patient information on clinical trials
• Your oncology team - They often know about trials matching your specific case
• Advocacy organizations - Breast Cancer Research Foundation, Susan G. Komen, and others often maintain trial databases

Important Note

The specific trials available to you depend heavily on:

• Your hormone receptor status (HR+/HR-)
• Your HER2 status
• Specific mutations in your tumor (PIK3CA, ESR1, BRCA, etc.)
• Prior treatments you've received
• Your overall health status
• Your location

Your oncologist is the best resource for identifying which trials match YOUR specific situation. They can review your pathology, biomarkers, and medical history to recommend appropriate options.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.